Stockreport

Whitehawk Therapeutics Presents Comprehensive Preclinical Data Highlighting its Next-Generation ADC Portfolio at the AACR 2026 [Yahoo! Finance]

Whitehawk Therapeutics, Inc.  (WHWK) 
PDF Tumor regressions observed across various cancer models at low single - digit mg/kg doses, with favorable tolerability (HNSTD 60 mg/kg) and low systemic levels of free [Read more]